Europe Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 237 | Pages: 132 | December 2016 | Region: Europe


The Europe Plasma Protein Therapeutic Market is a USD 4.42 Billion market in 2015 and is expected to reach $6.37 Billion by 2020 with a staggering CAGR of 7.6%. The usage of plasma proteins have increased significantly in the medical application owing to the new introductions in plasma-derived therapies. The advancements in technology has made the process of extracting protein from plasma more efficient and cost saving and is aiding the growth of the market. WHO reports indicates that more than half of the blood donors are from high income nations which accounts only for 18% of the population. Government initiatives and increasing awareness regarding the blood donations is believed to help the growth of the market.

Plasma is a protein rich fluid which is responsible for blood clotting and providing immunity towards diseases. Isolation of these proteins from plasma can be helpful to provide medical therapies which includes immune deficiencies, autoimmune, neurological and bleeding disorders. Plasma protein therapies helps in replacing the deficient or missing proteins and helps the individual to lead a normal life. The therapies involves either the injection or infusion of the biological medicines as a treatment to life-threatening genetic and chronic diseases.

The market is driven by a host of factors which include increased introduction of new plasma-derived therapies, rise in life threatening diseases which involves immune and neurological systems like chronic inflammatory demyelinating polyneuropathy (CIPD), Ideopathic thrombocytopenic purpura (ITP) and infectious diseases like Hepatitis A&B, Tetanus, Rabies and varicella. However, factors like stringent policies by the government, complexity in manufacturing the proteins reimbursement must be taken care of in order for the market to prosper in the future.

The Europe Plasma Protein Therapeutics Market is classified into various categories based on the type of the product as alpha-1 proteinase inhibitor, Coagulation Factors, Immunoglobulins, Albumin and others. Based on applications, the market is segmented in to Hemophilia, Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiency Disorder, Secondary Immunodeficiency and others. On the basis of geography, Europe market is segmented in to United Kingdom, Germany, Italy, France, Spain and others.

The major companies the Plasma Protein Therapeutics industry are Baxter, China Biologics, Grifols, Octopharma, Kedrion, shire Plc., CSL Behring, Biotest and Chengdu Inst.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 Others                                                      

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  2. Europe Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)
  3. Europe Immunoglobulins Market By Region, From 2015-2020 (USD Billion)
  4. Europe Albumin Market By Region, From 2015-2020 (USD Billion)
  5. Europe Coagulation Factors Market By Region, From 2015-2020 (USD Billion)
  6. Europe Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)
  7. Europe Others Market By Region, From 2015-2020 (USD Billion)
  8. Europe Hemophilia Market By Region, From 2015-2020 (USD Billion)
  9. Europe Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)
  10. Europe Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)
  11. Europe Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)
  12. Europe Others Market By Region, From 2015-2020 (USD Billion)
  13. U.K Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  14. Spain Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  15. Germany Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  16. Italy Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  17. France Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  18. U.K Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)
  19. Spain Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)
  20. Germany Plasma Protein Therapeutics Market By Applciation, From 2015-2020 (USD Billion)
  21. Italy Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)
  22. France Plasma Protein Therapeutics Market By Application From 2015-2020 (USD Billion)
Middle East And Africa Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical,...
Latin America Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Fo...
Asia Pacific Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Foo...
Europe Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Food, Che...
North America Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Fo...
Industrial Alcohol Market By Type (Ethyl, Methyl, Isopropyl, Isobutyl, Benzyl Alcohol), By Source (Sugar & Molasses, Corn, Grains, Fossil Fuels), By Application (Personal Care, Pharmaceutical, Fuel, Food, Chemical) ...
Middle East And Africa Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Indu...
Latin America Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Anal...
Asia Pacific Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Analy...
Europe Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Analysis, S...
North America Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Industry Anal...
Protein Hydrolysis Enzyme Market By Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry And Others) And By End User And By Region - Global Industry Analysis, S...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.